Create and release your Profile on Zintellect – Postdoctoral applicants must create an account and complete a profile in the on-line application system. Please note: your resume/CV may not exceed 3 pages.
Complete your application – Enter the rest of the information required for the IC Postdoc Program Research Opportunity. The application itself contains detailed instructions for each one of these components: availability, citizenship, transcripts, dissertation abstract, publication and presentation plan, and information about your Research Advisor co-applicant.
Additional information about the IC Postdoctoral Research Fellowship Program is available on the program website located at: https://orise.orau.gov/icpostdoc/index.html.
If you have questions, send an email to ICPostdoc@orau.org. Please include the reference code for this opportunity in your email.
Research Topic Description, including Problem Statement:
Prions are transmissible, self-templating protein agents that can induce abnormal folding of specific cellular proteins called cellular prion proteins (PrPc) which are found in the brain of most organisms*1. The onset of diseases linked to prions is typically followed by a rapid clinical progression of neurological deterioration, which results in a lethal outcome. Creutzfeldt–Jakob disease in humans *2, scrapie in sheep and goats *3, chronic wasting disease in cervids *4, and bovine spongiform encephalopathy *5 are well-known variants of these transmissible diseases. Certain non-infectious diseases, such as Alzheimer’s *6, Parkinsons *7, and type 2 diabetes *8, also have linkages to abnormal protein conformations. Recent discoveries have described infectious transmission of amyloid-beta in humans, leading to iatrogenic cerebral amyloid angiopathy *9. Research of amyloid-like proteins in yeast and other fungi has described numerous prion-like formations and molecular control mechanisms for the host cell, and how it manages formation of these amyloid proteins, limiting detrimental impact and while also leading to potential benefit for the community *10.
While research in the past decades has drastically improved our understanding of prion, prion-like, and amyloid proteins to include structural *11, model hosts *12, and computational prediction *13, *14, the focus of published data is biased towards a limited number of severe diseases. The recognition of prion-like formations in yeast, especially those potentially with beneficial non-Mendelian inheritance traits *15, as well as novel human diseases, demonstrate how little the academic and clinical community know about these proteins and the potential range of functions they serve at a molecular, cellular, organismal, and community level. Further study on prions and prion-like proteins is essential; as a greater breadth of knowledge will improve capabilities to predict lethality, transmissibility, host specificity, environmental stability, tissue specificity, and/or disease severity, improving surveillance efforts and advance novel medical countermeasures. Proposers are encouraged to consider a wider definition of aggregate-prone proteins, including those with temperature sensitive or misfolded states with potential for altered function.
References:
1 “Prion Diseases | CDC.”
2 Uttley et al., “Creutzfeldt-Jakob Disease.”
3 Acín et al., “Classical and Atypical Scrapie in Sheep and Goats. Review on the Etiology, Genetic Factors, Pathogenesis, Diagnosis, and Control Measures of Both Diseases.”
4 Rivera et al., “Chronic Wasting Disease In Cervids.”
5 Collinge, “Human Prion Diseases and Bovine Spongiform Encephalopathy (BSE).”
6 Ma, Hong, and Yang, “Amyloidosis in Alzheimer’s Disease.”
7 Araki et al., “Parkinson’s Disease Is a Type of Amyloidosis Featuring Accumulation of Amyloid Fibrils of a-Synuclein.”
8 Marzban, Park, and Verchere, “Islet Amyloid Polypeptide and Type 2 Diabetes.”
9 Banerjee et al., “Iatrogenic Cerebral Amyloid Angiopathy.”
10 Liebman and Chernoff, “Prions in Yeast.”
11 Terry et al., “Structural Features Distinguishing Infectious Ex Vivo Mammalian Prions from Non-Infectious Fibrillar Assemblies Generated in Vitro.”
12 Liebman and Chernoff, “Prions in Yeast.”
13 Afsar Minhas, Ross, and Ben-Hur, “Amino Acid Composition Predicts Prion Activity.”
14 Charoenkwan et al., “AMYPred-FRL Is a Novel Approach for Accurate Prediction of Amyloid Proteins by Using Feature Representation Learning.”
15 Chakrabortee et al., “Intrinsically Disordered Proteins Drive Emergence and Inheritance of Biological Traits.”
Example Approaches:
Researchers seeking to reply to this topic should seek to advance our knowledge of prion or prion-like, and/or amyloid proteins beyond the well-studied disease descriptions known today. Such research should aim to expand the database of known or suspect targets through the development of new tools and leveraging of existing structural/mechanistic activities. With such studies, it is hoped that the academic and clinical communities may be able to better understand the impact of protein-based inheritance. This work may improve capabilities to detect, characterize, and model novel proteins which may be beneficial or detrimental to host systems. Proposed research efforts can be pursued in vitro, in vivo, and/or in silico but all proposals must describe advancing the current state of knowledge for the potential breadth of natural or unnatural prion and prion-like proteins.
Relevance to the Intelligence Community:
The S&T priority on biotechnology directly aligns with this research topic as Synthetic biology, biotechnology, infectious diseases, biological sciences, biosurveillance, bioconvergence, biointelligence
Key Words: prions, cryogenic electron microscopy, structural biology, amyloid proteins, filamentous polymers, amyloid-beta, prionoids
The ORISE GO mobile app helps you stay engaged, connected and informed during your ORISE experience – from application, to offer, through your appointment and even as an ORISE alum!
You gave a rating of 0 star(s)
SECURITY/PRIVACY NOTICE
By continuing to use this system you indicate your awareness of and consent to the following terms and conditions of use. LOGOUT IMMEDIATELY if you do not agree to the conditions stated in this warning.
SECURITY NOTICE
This system is part of a Federal information system. This system is monitored for security purposes to ensure it remains available to all users and to protect information in the system. The system employs software programs to monitor network traffic to identify unauthorized activities. By accessing this system, you are expressly consenting to these monitoring activities. Unauthorized attempts to defeat or circumvent security features; to use the system for other than intended purposes; to deny service to authorized users; to access, obtain, alter, damage, or destroy information; to upload or change information; to otherwise cause system or information damage; or otherwise to interfere with the system or its operation, is prohibited. Evidence of such acts may be dis-closed to law enforcement authorities and result in prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996, or other applicable laws.
PRIVACY NOTICE
This system is for authorized use only. Use of this system constitutes consent to security monitoring and testing. All activity is logged with your host name and IP address. Users (authorized or unauthorized) have no explicit or implicit expectation of privacy. Any or all uses of this system and all files on this system may be intercepted, monitored, recorded, copied, audited, inspected, and dis-closed to authorized site and law enforcement personnel, as well as authorized officials of other agencies, both domestic and foreign. By using this system, the user consents to such interception, monitoring, recording, copying, auditing, inspection, and disclosure at the discretion of authorized site or law enforcement personnel. Unauthorized or improper use of this system may result in administrative disciplinary action and civil and criminal penalties.
You have been inactive on this page for . You will be logged out after 03:00:00.
Select an icon below to visit the website and download an appropriate browser.
For help, please email Zintellect@orau.org.
Question: What is the deadline for submitting an application?
Answer: Not all opportunities have application deadlines. Some opportunities remain open until they are filled. If an opportunity has an application deadline, then it will be listed in the opportunity details or in the opportunity catalog.
Question: How do I reset my password?
Answer: If you have forgotten your password or wish to reset your password, use the "Forgot password or username?" tab on the login to reset it.
Question: I forgot my username. How do I retrieve it?
Answer: Use the "Forgot password or username?" tab on the login. You will receive an email containing your username.
Question: What do I need to submit an application?
Answer: Typically, applicants are required to submit a resume or CV, an official copy of their transcripts or academic record, and a minimum of two references at the time they apply. Additional requirements such as a writing sample, thesis or dissertation, etc. may be required. Review the opportunity details for additional information about the requirements for applying for an opportunity.
Question: Where do I upload my transcripts?
Answer: If required, you will be asked to upload your transcript as a part of the application process.
Question: Where do I submit a writing sample?
Answer: If required, you will be asked to upload a writing sample as part of the application process.
Question: Can a family member serve as a reference?
Answer: No; family members may not serve as references. References must be able to speak to your educational and/or professional experience. At least one academic reference is preferred.
Our Zintellect A.I. is constantly learning how to Match you to our opportunities! So, we want to know when we get it right or when we get it wrong. This will help us make our better! Plus, as a potential applicant to one of our many opportunities across the country, we value you and want to help you on your career path!